Humans die of old age because the body accumulates damage at every level of organization, from individual molecules to entire organ systems, and eventually the repair machinery can no longer keep up. There is no single “aging gene” or one broken part that kills you. Instead, dozens of interacting processes, from shortening chromosome caps to a failing immune system to a gut lining that slowly leaks bacteria into the bloodstream, converge until some critical threshold is crossed. What makes the biology especially interesting is that evolution not only failed to prevent this decline but, in many cases, actively selected for the genes that cause it.
Why Evolution Built Us to Break Down
The most common intuition about aging is that it represents wear and tear, like a machine running past its warranty. That is partly true at the cellular level, but it misses a deeper question: why didn’t natural selection just build a body that repairs itself indefinitely? The answer, broadly, is that evolution does not care what happens to you after you have successfully reproduced. Genes that boost fertility or survival in early life get passed on even if those same genes cause harm decades later. This idea, called antagonistic pleiotropy, was proposed in the 1950s and has since been confirmed at the molecular level. In the roundworm C. elegans, researchers identified a gene called trl-1 that suppresses the production of yolk protein, extending lifespan. When the gene is knocked out, the worms produce more eggs but die sooner, because overproduction of yolk protein is toxic over time.
That is not just a worm phenomenon. A 2025 study in humans identified eight genetic variants with effects on both fertility and lifespan, and seven of them followed the antagonistic pleiotropy pattern: the version of the gene that enhanced fertility was associated with reduced longevity.1Nature Ecology & Evolution. Genetic trade-offs in fertility and longevity explain the maintenance of disease-associated alleles in humans These are not obscure lab curiosities. They are direct evidence that some of the alleles circulating in the human population right now exist precisely because they help people have children, even though they shorten lives.
A related idea, the disposable soma theory, frames the problem as an energy budget. Your body has limited resources, and it has to divide them between reproduction and self-repair. Investing heavily in maintaining your own tissues means fewer resources for producing and provisioning offspring.2PubMed Central. Disposable Soma Theory and the Evolution of Maternal Effects on Ageing This trade-off has been demonstrated experimentally in vertebrates: when researchers removed the germline (the cells that produce eggs and sperm) in fish, the animals healed from injuries faster, because the energy previously devoted to maintaining reproductive cells was redirected to somatic repair.3PubMed Central. Trade-off between somatic and germline repair in a vertebrate supports the expensive germ line hypothesis In other words, your body is built to be disposable. Once you have passed your genes on, the evolutionary pressure to keep you in good shape weakens dramatically.
The Cellular Countdown
At the cellular level, one of the best-known aging mechanisms involves telomeres, the protective caps on the ends of your chromosomes. Every time a cell divides, these caps get a bit shorter. After enough divisions, the telomeres become critically short, and the cell enters a state called senescence, where it stops dividing permanently.4PubMed. The Connection Between Cell Fate and Telomere This is sometimes called the Hayflick limit, after the biologist who first noticed that normal human cells can only divide a fixed number of times. Cancer cells get around this by activating an enzyme called telomerase, which rebuilds their telomeres, allowing them to divide indefinitely.5British Journal of Cancer. The illusion of cell immortality Normal cells in your body generally do not have this option.
Senescent cells are not simply dead cells waiting to be cleaned up. They stay metabolically active and pump out a cocktail of inflammatory signals, growth factors, and tissue-remodeling enzymes collectively known as the senescence-associated secretory phenotype, or SASP. In small doses and for short periods, this response is useful: it helps with wound healing and signals the immune system to clear damaged tissue. But when senescent cells accumulate with age, the chronic output of these signals drives inflammation, promotes scarring in organs, and can even encourage tumor growth.6PubMed Central. SASP Modulation for Cellular Rejuvenation and Tissue Homeostasis: Therapeutic Strategies and Molecular Insights The effect of senescent cells depends heavily on context: which tissue they are in, what triggered their senescence, and how long they have been sitting there.7PubMed Central. Impact of Senescent Cell Subtypes on Tissue Dysfunction and Repair: Importance and Research Questions Early on, they can suppress tumors and help repair tissue. Later, they become a major source of the chronic low-grade inflammation that characterizes old age.
Accumulating Errors in the Genome
Beyond telomere shortening, the DNA itself accumulates mutations over a lifetime. Every cell division carries a small risk of copying errors, and environmental exposures (ultraviolet light, chemical pollutants, even normal metabolic byproducts) damage DNA between divisions. Repair mechanisms catch most of these errors, but not all. Over decades, the random mutations pile up in somatic cells, occasionally knocking out genes that a particular tissue needs to function properly.8PubMed Central. Somatic mutations in aging, cancer and neurodegeneration When enough cells in an organ have accumulated enough damage, organ function declines. This is part of why cancer risk rises so steeply with age: the more mutations a cell has collected, the more likely one of them will disable a growth-suppression gene.
There is also a layer of information on top of the DNA sequence itself, called the epigenome, that changes predictably with age. Researchers have built “epigenetic clocks” by measuring chemical tags (specifically, methyl groups attached to DNA) at hundreds of specific sites across the genome. The aggregate pattern of these tags can estimate a person’s chronological age with striking accuracy, and deviations from the expected pattern appear to reflect biological aging: a person whose methylation pattern looks older than their actual age tends to face higher disease risk.9PubMed Central. DNA Methylation Clocks in Aging: Categories, Causes, and Consequences These clocks work across multiple tissues and cell types, suggesting that epigenetic drift is a body-wide phenomenon, not something confined to one organ.10PubMed Central. DNA methylation age of human tissues and cell types Whether the methylation changes themselves cause aging or merely reflect deeper processes is still debated, but they are already being used to test whether interventions (caloric restriction, specific drugs) slow or reverse biological aging.11PubMed Central. DNA methylation aging clocks: challenges and recommendations
Protein Jams and Failing Power Plants
Your cells depend on proteins folding into precise three-dimensional shapes to do their jobs. A network of molecular machines constantly monitors, refolds, and recycles misfolded proteins. With age, this quality-control system degrades. Misfolded proteins clump together into aggregates that cells cannot easily clear, and these aggregates interfere with normal cellular operations.12PubMed Central. The biology of proteostasis in aging and disease In the brain, protein aggregation is the hallmark of conditions like Alzheimer’s and Parkinson’s disease, but it occurs to some extent in virtually every tissue.
Meanwhile, the mitochondria, the structures inside cells that generate energy, suffer their own age-related decline. Mitochondria have their own small genome, and damage to it impairs their ability to produce energy efficiently. Damaged mitochondria leak reactive oxygen species, highly reactive molecules that damage proteins, lipids, and DNA in the surrounding cell. This creates a vicious cycle: damaged mitochondria produce more reactive oxygen species, which damage more mitochondria, which fuels chronic low-grade inflammation.13PubMed Central. Targeting the Electron Transport System for Enhanced Longevity
Tying many of these processes together is a nutrient-sensing pathway centered on a protein complex called mTOR. When food is abundant, mTOR signals cells to grow and divide. When nutrients are scarce, mTOR activity drops, and cells shift into a maintenance-and-repair mode. The problem is that in well-fed modern humans, mTOR tends to stay chronically active, pushing cells toward growth rather than upkeep. Inhibiting mTOR with drugs like rapamycin extends lifespan in laboratory animals, and overactivation of mTOR through excess nutrition is linked to cancer, type 2 diabetes, and obesity.14PubMed Central. The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging The connection between mTOR and lifespan has been demonstrated across yeast, worms, flies, and mice, making it one of the most conserved aging mechanisms known.15PubMed Central. mTOR is a key modulator of ageing and age-related disease mTOR sits at the intersection of several aging hallmarks, including protein quality control, the clearance of damaged cellular components, mitochondrial function, and the accumulation of senescent cells.16PubMed Central. mTOR as a central regulator of lifespan and aging
The Slow Fire of Chronic Inflammation
If you zoom out from individual cells to the whole body, one of the most striking features of aging is a persistent, low-level inflammatory state sometimes called “inflammaging.” Most older adults develop elevated levels of inflammatory markers in their blood, and this background inflammation is associated with cardiovascular disease, frailty, disability, and earlier death.17PubMed Central. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty The sources of this inflammation are numerous: senescent cells secreting inflammatory signals, malfunctioning mitochondria, a gut barrier that becomes leakier with age (allowing bacterial products to seep into the bloodstream), shifts in the composition of gut bacteria, and a gradual decline in the immune system’s ability to regulate itself.18Signal Transduction and Targeted Therapy. Inflammation and aging: signaling pathways and intervention therapies
The gut-barrier connection deserves special attention because it is often overlooked in popular accounts of aging. As the intestinal lining deteriorates with age, microbial products cross into the bloodstream and trigger immune responses. In aged mice, this barrier breakdown has been shown to elevate blood levels of inflammatory markers and drive systemic inflammation.19PubMed Central. Intestinal barrier dysfunction: an evolutionarily conserved hallmark of aging This is not just a mouse phenomenon; gut permeability increases have been documented in aging monkeys and humans as well. What makes inflammaging particularly insidious is that it is self-reinforcing: inflammation damages tissues, damaged tissues produce more inflammatory signals, and the immune system becomes less efficient at resolving the inflammation, all at the same time.
Running Out of Spare Parts
Your body maintains pools of stem cells in various tissues, from bone marrow to the lining of the gut, that divide to replace worn-out or damaged cells. With age, these stem cell pools shrink and their remaining cells become less functional.20PubMed Central. Stem cell aging: mechanisms, regulators and therapeutic opportunities The decline is driven by many of the same processes already described: accumulated DNA damage, epigenetic drift, metabolic changes inside the stem cells themselves, and a deteriorating environment in the tissues that house them.21Cell Metabolism. Regulation of Stem Cell Aging by Metabolism and Epigenetics When stem cells can no longer replenish a tissue fast enough, the tissue loses its ability to heal and maintain itself. This is why a cut on the skin of a seventy-year-old heals more slowly than the same cut on a twenty-year-old, and why elderly people are more vulnerable to infections: the bone marrow produces fewer and less effective immune cells.
One of the more dramatic demonstrations of how the aging environment matters comes from parabiosis experiments in mice, where the circulatory systems of a young and an old mouse are surgically joined. The old mouse shows measurable rejuvenation: reduced senescent cells in the spleen, liver, skin, and brain, and improved stem cell function across multiple tissues.22Cell. A multi-tissue single-cell transcriptomic atlas of heterochronic parabiosis Young blood appears to contain circulating factors that counteract aging at the tissue level, and many of these factors become less abundant as an organism ages.23PubMed Central. Circulating plasma factors involved in rejuvenation These experiments do not mean that transfusing young blood into elderly people is a viable therapy (the translation from surgically joined mice to clinical medicine is enormous), but they do reveal something important about the biology: aging is not just a property of individual cells. It is also a property of the systemic environment those cells live in.24PubMed Central. Young Blood Rejuvenates Old Bodies: A Call for Reflection when Moving from Mice to Men
What Actually Kills You in Extreme Old Age
When researchers perform autopsies on centenarians, the pattern of disease looks different from what you would find in someone who died in their sixties or seventies. Cancer, while still present, is substantially less common and tends to be less aggressive. An autopsy study comparing centenarians to the broader aging population found cancer in about 16% of centenarians versus 39% of younger elderly people, and the cancers that were present had metastasized far less often.25Archives of Gerontology and Geriatrics. Autopsy reports in extreme longevity By contrast, degenerative diseases of the brain were more common and more severe in centenarians. Autopsy studies of supercentenarians (people who lived past 110) have found that age-related brain changes were mild to moderate compared to what might be expected, suggesting some degree of neuroprotective advantage, but tau-related changes in the brain were still consistently present.26PubMed Central. Neuropathology of supercentenarians – four autopsy case studies
For many of the oldest old, death does not arrive via a single dramatic disease. Instead, the aggregate decline across multiple systems produces a state called frailty, where the body’s reserves are so depleted that even a minor stressor (a fall, a mild infection, a brief period of reduced food intake) can trigger a fatal cascade. Some very elderly people are frail without having any single life-threatening illness.27PubMed. Aging, frailty and age-related diseases Their cardiovascular system, kidneys, immune system, and musculature have all declined to the point where the body simply cannot mount an adequate response to a challenge that a younger person would shrug off. This is the biological reality behind the phrase “died of old age”: not one cause, but the convergence of many.
The Mathematics of Mortality
One of the most reliable patterns in human biology is Gompertz’s law: after about age 30, your risk of dying roughly doubles every eight years. This exponential increase in mortality holds remarkably well across populations and time periods.28Journal of Health Economics. How do we age? A decomposition of Gompertz law A study applying this pattern to surgical mortality confirmed that the inflection point for sharply rising risk appears around age 30, with a strict exponential increase thereafter.29PubMed. Biodemography of Human Aging (Gompertz-Makeham Law) Applied to Surgical Mortality Modeling: A Retrospective National Cohort Study This is the mathematical fingerprint of the biological processes described in this article: the damage accumulates gradually, but its consequences compound.
There is, however, a strange twist at the very far end of the lifespan. After about age 105, the exponential increase in mortality appears to level off, producing what demographers call a mortality plateau. A large study of Italian semi-supercentenarians found essentially flat hazard curves beyond age 105.30PubMed Central. The plateau of human mortality: Demography of longevity pioneers This does not mean that people stop dying; the annual risk of death at 105 is extremely high (roughly 50-50 in any given year). But the risk stops accelerating. Why this happens is unclear. One possibility is that the most vulnerable individuals have already died, leaving a highly selected group whose biology is unusually resistant to further decline. Another is that the mechanisms driving the exponential increase have largely run their course by that age, and what remains is essentially a coin flip each year.
Drugs That Target Aging Cells
The growing understanding of why we age has inspired efforts to intervene directly. One of the most active research areas involves senolytic drugs, compounds designed to selectively kill senescent cells. The logic is straightforward: if senescent cells and their inflammatory secretions drive much of age-related decline, removing them should slow or reverse that decline. In animal studies, the results have been encouraging. Intermittent treatment of naturally aged mice with a senolytic combination increased their remaining lifespan by about 36% and reduced their mortality risk to roughly 65% of untreated mice.31Nature Medicine. Senolytics improve physical function and increase lifespan in old age Preclinical data across multiple studies suggest that senolytics alleviate disease in numerous organs and improve physical function, even when administered late in life.32PubMed Central. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span
A related class of compounds called senomorphics take a different approach: rather than killing senescent cells, they suppress the inflammatory signals those cells produce. Both strategies have shown promise in animal models for preventing or treating age-related diseases.33PubMed Central. Senotherapeutics: emerging strategy for healthy aging and age-related disease Human trials are in early stages, and it remains to be seen whether the dramatic results in mice will translate to people. The biology of human aging involves longer timescales, more complex immune systems, and a broader range of senescent cell types than any mouse model captures. Still, the field has moved from describing aging as an inevitable mystery to treating it as a set of tractable biological problems, each with potential points of intervention.
Why Some Species Barely Age at All
Not every animal declines the way humans do. Certain long-lived species appear to have evolved mechanisms that counteract the aging processes described above. Naked mole-rats, for instance, live roughly ten times as long as similarly sized rodents, show minimal age-related increase in cancer rates, and maintain stem cell function far longer than expected. Bowhead whales live over two centuries. Greenland sharks may reach several hundred years. Studying these outliers has revealed that some anti-aging strategies are shared across species (enhanced DNA repair, for instance), while others are entirely novel adaptations unique to particular lineages.34PubMed Central. Revelations About Aging and Disease from Unconventional Vertebrate Model Organisms The existence of these species shows that the biological constraints on lifespan are not absolute physical laws; they are engineering compromises shaped by each species’ ecology and reproductive strategy. Evolution could, in principle, have built humans to last longer, but only at the cost of something else, likely reproductive output or early-life vigor, that mattered more for survival in our ancestral environment.